招募中 NCT06426563

用于治疗中等大小良性甲状腺结节的MWA与RFA

皮肤癌不适用

甲状腺结节是一种常见的疾病,影响多达60 %的人口。估计发生甲状腺结节的终生概率为10 %。虽然大多数甲状腺结节是良性的,但高达10-15%的结节会扩大,导致压迫性症状,包括颈部压力和不适、吞咽困难、呼吸困难和发音困难。这些良性但有问题的结节的传统治疗方法是甲状腺切除术。

适应症:Thyroid Nodule \(Benign\)、Ablation Therapy

入组条件

纳入标准

  • Adult patients \>/=18 years of age
  • Nodule maximal diameter ≥2cm and nodule volume \<20ml
  • Nodule being predominantly solid (≥80% solid)
  • Confirmed benign nature of nodules, either by : two benign fine needle biopsies, with the most recent biopsy performed within 1 year of enrollment in study or one benign fine needle biopsy and low suspicion characteristics on ultrasound
  • Both functional and non-functional nodules are eligible.

排除标准

  • Cytologically indeterminate nodules
  • Nodules with substernal extension or posterior extension that cannot be viewed sufficiently with ultrasound
  • current pregnancy or cardiac arrhythmias; presence of pacemaker or any medical condition that renders patient unfit for thermal ablation

入组条件维持 ClinicalTrials.gov 原始英文登记资料,实际入组资格以研究团队的正式评估与受试者知情同意书为准。资料来源:ClinicalTrials.gov,每两周自动更新,最后同步:2026年10月8日。